Lumenis Laser Therapy for Glaucoma

Selective Laser Trabeculoplasty is clinically proven to treat glaucoma by safely and effectively reducing intraocular pressure in a single, office procedure.

SLT can be an effective adjunct to medication therapy or used as a primary treatment to reduce or eliminate the need for topical glaucoma medications, along with their common systemic side effects.

SLT has the potential to save your patients thousand of dollars in prescription medication costs and improve compliance.

How does SLT achieve lower pressure without damage to the trabecular meshwork?

The underlying mechanism is selective photothermalysis that enables the laser to precisely target intracellular melanin granules to activate individual cells while not disturbing adjacent non-pigmented cells. The activated cells release cytokines that trigger a targeted macrophage response to the trabecular meshwork cells. The macrophages reactivate the meshwork reducing fluid outflow resistance and lowering intraocular pressure.

Advantages of Selecta II for SLT Laser Therapy

• Proven to reduce IOP
  
• No systemic side effects
  
• A single treatment therapy
  
• Effective as primary, adjunct or repeat therapy
  
• Safe, office-based procedure
  
• Protects trabecular meshwork
  
• Improves patient compliance
  
• Medicare reimbursed

Procedures & Technologies

• Cataract Removal (No Needle, No Stitches)
• LASIK Vision Correction - with the CustomVue System
• Pneumatic Retinopexy
• Vitrectomy
• YAG Laser Capsulotomy Surgery for After Cataracts
• Lucentis Injection for Macular Degeneration
• Dr. Gupta uses the PASCAL for rentinal diseases - DuPage Medical Group has two PASCAL machines.
• For Angiography, an OPTOS P200MA wide field camera is used
• Lumenis SLT Laser

• Home
  
• Our Physicians
  
• Services
  
• Locations & Contact Us